Clinical Trial Update: Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer

View source ↗

Summary

A clinical trial evaluating saliva testing for high-risk human papillomavirus infection in oral cavity and oropharyngeal cancers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Oropharyngeal Squamous Cell Carcinoma, Human Papillomavirus Infection | Status: WITHDRAWN